Free Trial

Danaher (DHR) Competitors

Danaher logo
$179.95 -0.15 (-0.08%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$180.33 +0.38 (+0.21%)
As of 06/12/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DHR vs. RGEN, TECH, A, CR, and CSL

Should you buy Danaher stock or one of its competitors? MarketBeat compares Danaher with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Danaher include Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), Crane (CR), and Carlisle Companies (CSL).

How does Danaher compare to Repligen?

Danaher (NYSE:DHR) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, Danaher had 39 more articles in the media than Repligen. MarketBeat recorded 46 mentions for Danaher and 7 mentions for Repligen. Repligen's average media sentiment score of 1.17 beat Danaher's score of 1.07 indicating that Repligen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
33 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Repligen
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Danaher has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Repligen has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

Danaher currently has a consensus target price of $233.61, suggesting a potential upside of 29.82%. Repligen has a consensus target price of $164.64, suggesting a potential upside of 26.08%. Given Danaher's higher probable upside, equities research analysts plainly believe Danaher is more favorable than Repligen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.84
Repligen
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
2.88

Danaher has higher revenue and earnings than Repligen. Danaher is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$24.57B5.18$3.61B$5.1734.81
Repligen$738.26M9.98$48.89M$0.90145.10

Danaher has a net margin of 14.89% compared to Repligen's net margin of 6.73%. Danaher's return on equity of 10.91% beat Repligen's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher14.89% 10.91% 6.94%
Repligen 6.73%4.88%3.48%

79.1% of Danaher shares are held by institutional investors. Comparatively, 97.6% of Repligen shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Comparatively, 0.6% of Repligen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Danaher beats Repligen on 10 of the 17 factors compared between the two stocks.

How does Danaher compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Danaher (NYSE:DHR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Bio-Techne has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Danaher has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 79.1% of Danaher shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by insiders. Comparatively, 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Danaher has a net margin of 14.89% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Techne9.05% 13.57% 10.66%
Danaher 14.89%10.91%6.94%

Danaher has higher revenue and earnings than Bio-Techne. Danaher is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Techne$1.22B6.93$73.40M$0.6978.26
Danaher$24.57B5.18$3.61B$5.1734.81

In the previous week, Danaher had 36 more articles in the media than Bio-Techne. MarketBeat recorded 46 mentions for Danaher and 10 mentions for Bio-Techne. Danaher's average media sentiment score of 1.07 beat Bio-Techne's score of 0.46 indicating that Danaher is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Techne
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Danaher
33 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.6%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Bio-Techne pays out 46.4% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Bio-Techne currently has a consensus price target of $65.15, suggesting a potential upside of 20.66%. Danaher has a consensus price target of $233.61, suggesting a potential upside of 29.82%. Given Danaher's stronger consensus rating and higher possible upside, analysts clearly believe Danaher is more favorable than Bio-Techne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Techne
1 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.67
Danaher
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.84

Summary

Danaher beats Bio-Techne on 13 of the 19 factors compared between the two stocks.

How does Danaher compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Danaher (NYSE:DHR) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Agilent Technologies has a net margin of 19.55% compared to Danaher's net margin of 14.89%. Agilent Technologies' return on equity of 24.33% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies19.55% 24.33% 12.99%
Danaher 14.89%10.91%6.94%

79.1% of Danaher shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.8%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Agilent Technologies pays out 20.5% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has increased its dividend for 9 consecutive years and Danaher has increased its dividend for 2 consecutive years.

Agilent Technologies has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Danaher has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

In the previous week, Danaher had 32 more articles in the media than Agilent Technologies. MarketBeat recorded 46 mentions for Danaher and 14 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.23 beat Danaher's score of 1.07 indicating that Agilent Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
10 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Danaher
33 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Danaher has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$6.95B5.27$1.30B$4.9826.06
Danaher$24.57B5.18$3.61B$5.1734.81

Agilent Technologies presently has a consensus target price of $160.93, indicating a potential upside of 24.03%. Danaher has a consensus target price of $233.61, indicating a potential upside of 29.82%. Given Danaher's higher probable upside, analysts plainly believe Danaher is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88
Danaher
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.84

Summary

Danaher beats Agilent Technologies on 10 of the 19 factors compared between the two stocks.

How does Danaher compare to Crane?

Crane (NYSE:CR) and Danaher (NYSE:DHR) are related large-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Crane presently has a consensus target price of $226.33, indicating a potential upside of 9.46%. Danaher has a consensus target price of $233.61, indicating a potential upside of 29.82%. Given Danaher's higher probable upside, analysts plainly believe Danaher is more favorable than Crane.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crane
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.13
Danaher
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.84

Crane has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, Danaher has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

In the previous week, Danaher had 34 more articles in the media than Crane. MarketBeat recorded 46 mentions for Danaher and 12 mentions for Crane. Crane's average media sentiment score of 1.19 beat Danaher's score of 1.07 indicating that Crane is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crane
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Danaher
33 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Crane pays an annual dividend of $1.02 per share and has a dividend yield of 0.5%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Crane pays out 18.3% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Crane has increased its dividend for 3 consecutive years and Danaher has increased its dividend for 2 consecutive years.

Danaher has a net margin of 14.89% compared to Crane's net margin of 13.10%. Crane's return on equity of 24.45% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Crane13.10% 24.45% 10.14%
Danaher 14.89%10.91%6.94%

75.1% of Crane shares are held by institutional investors. Comparatively, 79.1% of Danaher shares are held by institutional investors. 2.1% of Crane shares are held by insiders. Comparatively, 10.8% of Danaher shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Danaher has higher revenue and earnings than Crane. Danaher is trading at a lower price-to-earnings ratio than Crane, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crane$2.44B4.89$401.10M$5.5637.19
Danaher$24.57B5.18$3.61B$5.1734.81

Summary

Danaher beats Crane on 11 of the 20 factors compared between the two stocks.

How does Danaher compare to Carlisle Companies?

Danaher (NYSE:DHR) and Carlisle Companies (NYSE:CSL) are both large-cap industrial conglomerates companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Danaher currently has a consensus target price of $233.61, suggesting a potential upside of 29.82%. Carlisle Companies has a consensus target price of $405.00, suggesting a potential upside of 17.76%. Given Danaher's stronger consensus rating and higher probable upside, research analysts plainly believe Danaher is more favorable than Carlisle Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
0 Sell rating(s)
5 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.84
Carlisle Companies
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Danaher has higher revenue and earnings than Carlisle Companies. Carlisle Companies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$24.57B5.18$3.61B$5.1734.81
Carlisle Companies$5.02B2.77$740.70M$17.0120.22

Danaher has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Carlisle Companies has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

In the previous week, Danaher had 37 more articles in the media than Carlisle Companies. MarketBeat recorded 46 mentions for Danaher and 9 mentions for Carlisle Companies. Danaher's average media sentiment score of 1.07 beat Carlisle Companies' score of 0.83 indicating that Danaher is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
33 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Carlisle Companies
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Carlisle Companies pays an annual dividend of $4.40 per share and has a dividend yield of 1.3%. Danaher pays out 30.9% of its earnings in the form of a dividend. Carlisle Companies pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years and Carlisle Companies has increased its dividend for 48 consecutive years. Carlisle Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

79.1% of Danaher shares are held by institutional investors. Comparatively, 89.5% of Carlisle Companies shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Comparatively, 1.3% of Carlisle Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Danaher has a net margin of 14.89% compared to Carlisle Companies' net margin of 14.57%. Carlisle Companies' return on equity of 43.78% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher14.89% 10.91% 6.94%
Carlisle Companies 14.57%43.78%13.66%

Summary

Danaher beats Carlisle Companies on 12 of the 20 factors compared between the two stocks.

Get Danaher News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHR vs. The Competition

MetricDanaherMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$127.37B$8.90B$6.52B$23.31B
Dividend Yield0.89%1.71%2.67%4.05%
P/E Ratio34.8124.2324.0031.31
Price / Sales5.1823.90514.65100.04
Price / Cash15.8413.7327.4818.65
Price / Book2.425.5310.694.69
Net Income$3.61B$177.22M$3.57B$1.08B
7 Day Performance-1.92%1.54%0.61%2.07%
1 Month Performance11.12%10.04%1.56%3.44%
1 Year Performance-10.25%5.88%25.44%24.11%

Danaher Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHR
Danaher
4.715 of 5 stars
$179.95
-0.1%
$233.61
+29.8%
-10.3%$127.37B$24.57B34.8160,000
RGEN
Repligen
3.8864 of 5 stars
$131.18
+4.7%
$164.64
+25.5%
+2.4%$7.40B$763.34M145.862,000
TECH
Bio-Techne
3.7906 of 5 stars
$54.94
+4.4%
$65.17
+18.6%
+6.9%$8.59B$1.22B79.493,100
A
Agilent Technologies
4.9706 of 5 stars
$136.13
+2.6%
$161.71
+18.8%
+10.9%$38.47B$6.95B27.3518,100
CR
Crane
4.5345 of 5 stars
$199.03
+3.3%
$226.33
+13.7%
+14.1%$11.50B$2.44B26.3711,000

Related Companies and Tools


This page (NYSE:DHR) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners